Pascale Beurdeley

Pascale Beurdeley

(Paris, France)


Dr. Pascale Beurdeley is the Chief Scientific Officer of Pathoquest. She has 20 years experience in the biotechnology industry.

Prior to joining PathoQuest, Dr. Beurdeley held several positions at DiaxonHit (formerly ExonHit Therapeutics) with increasing responsibilities from Group Leader R&D to Executive Director R&D, Genomics.

Prior to joining ExonHit Therapeutics, Dr. Beurdeley held a researcher position in the translational medicine department at the Curie Institute. Dr. Beurdeley is graduated from the University Louis Pasteur (Strasbourg) and holds a Ph.D in Molecular and Cell Biology.

She completed her training as a postdoctoral fellow at Magainin Pharmaceuticals Inc, focusing on her interest in antimicrobial peptides.

All session by Pascale Beurdeley

  • Thursday19-Oct-2017

Experience of the development of iDTECT, the first NGS based CE-IVD test for pathogen detection